We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HIGHER-DOSE TAXUS STENT EFFECTIVE IN HIGH-RISK PATIENTS
HIGHER-DOSE TAXUS STENT EFFECTIVE IN HIGH-RISK PATIENTS
May 28, 2004
Results of the Taxus VI trial indicate that a higher-dose version of Boston Scientific’s paclitaxel-eluting stent is effective in preventing restenosis among high-risk patients, including diabetics.